. Cerebrovascular reactivity and hypercapnic respiratory drive in diabetic autonomic neuropathy. J Appl Physiol 90: [889][890][891][892][893][894][895][896] 2001.-Because abnormalities in cerebrovascular reactivity (CVR) in subjects with long-term diabetes could partly be ascribed to autonomic neuropathy and related to central chemosensitivity, CVR and the respiratory drive output during progressive hypercapnia were studied in 15 diabetic patients without (DANϪ) and 30 with autonomic neuropathy (DANϩ), of whom 15 had postural hypotension (PH) (DANϩPHϩ) and 15 did not (DANϩPHϪ), and in 15 control (C) subjects. During CO 2 rebreathing, changes in occlusion pressure and minute ventilation were assessed, and seven subjects in each group had simultaneous measurements of the middle cerebral artery mean blood velocity (MCAV) by transcranial Doppler. The respiratory output to CO 2 was greater in DANϩPHϩ than in DANϩPHϪ and DANϪ (P Ͻ 0.01), whereas a reduced chemosensitivity was found in DANϩPHϪ (P Ͻ 0.05 vs. C). MCAV increased linearly with the end-tidal PCO 2 (PET CO 2 ) in DANϩPHϪ but less than in C and DANϪ (P Ͻ 0.01). In contrast, DANϩPHϩ showed an exponential increment in MCAV with PET CO 2 mainly Ͼ55 Torr. Thus CVR was lower in DANϩ than in C at PET CO 2 Ͻ55 Torr (P Ͻ 0.01), whereas it was greater in DANϩPHϩ than in DANϩPHϪ (P Ͻ 0.01) and DANϪ (P Ͻ 0.05) at PET CO 2 Ͼ55 Torr. CVR and occlusion pressure during hypercapnia were correlated only in DANϩ (r ϭ 0.91, P Ͻ 0.001). We conclude that, in diabetic patients with autonomic neuropathy, CVR to CO 2 is reduced or increased according to the severity of dysautonomy and intensity of stimulus and appears to modulate the hypercapnic respiratory drive. diabetes; control of breathing A HIGHER RATE OF MORTALITY HAS been extensively reported in diabetic patients with autonomic neuropathy (DANϩ) compared with diabetic patients without dysautonomy (43). In DANϩ, most deaths occur suddenly during stressing conditions and/or sleep and have often been attributed to cardiorespiratory events (12, 28, 36) . Hence, a number of studies have investigated the influence of the diabetic dysautonomy on the control of breathing (19, 24, 35, 42) , leading, however, to controversial results. In fact, whereas a consistent decrease in hypoxic drive has been found in DANϩ, indicating a reduced peripheral chemosensitivity in these subjects (24, 27, 34, 42) , conflicting results have been reported, as far as the central chemosensitivity was concerned, as increased (27), normal (34, 35) , and decreased (19, 24, 40, 42) responses of the respiratory drive to hypercapnia have been described in similar populations of DANϩ. Recently, by splitting DANϩ into two groups that were characterized, according to the standard cardiovascular tests (13), by the presence of either parasympathetic and sympathetic damage with postural hypotension (PH) (DANϩPHϩ) or predominant parasympathetic damage without PH (DANϩPHϪ), we were able to show an increased response of the respiratory centers to progressive hypercapnia in the former group, whereas the opposite was found in the latter (38). These findings may suggest a modulatory effect of the sympathetic arm of the autonomic nervous system on the CO 2 responsiveness of the respiratory centers that, in fact, is enhanced when the sympathetic activity is markedly decreased, as in DANϩPHϩ, and reduced when this is not counterbalanced, as in DANϩPHϪ. The operating mechanism, however, is unknown. Because abnormalities in cerebrovascular reactivity (CVR) to different stimuli have been shown in large subsets of patients with long-lasting diabetes, many of whom were young and possibly suffering from autonomic neuropathy (11), we reasoned that, besides a potential direct mechanism, the sympathetic nervous system could indirectly influence the respiratory center output by regulating the cerebral blood flow (CBF) in the presence of effective stimuli. To verify this hypothesis, the CVR to CO 2 was assessed in diabetic patients with different degrees of dysautonomy, while the ventilatory and neuromuscular response of the respiratory drive to progressive hypercapnia was monitored.
A HIGHER RATE OF MORTALITY HAS been extensively reported in diabetic patients with autonomic neuropathy (DANϩ) compared with diabetic patients without dysautonomy (43) . In DANϩ, most deaths occur suddenly during stressing conditions and/or sleep and have often been attributed to cardiorespiratory events (12, 28, 36) . Hence, a number of studies have investigated the influence of the diabetic dysautonomy on the control of breathing (19, 24, 35, 42) , leading, however, to controversial results. In fact, whereas a consistent decrease in hypoxic drive has been found in DANϩ, indicating a reduced peripheral chemosensitivity in these subjects (24, 27, 34, 42) , conflicting results have been reported, as far as the central chemosensitivity was concerned, as increased (27) , normal (34, 35) , and decreased (19, 24, 40, 42) responses of the respiratory drive to hypercapnia have been described in similar populations of DANϩ. Recently, by splitting DANϩ into two groups that were characterized, according to the standard cardiovascular tests (13) , by the presence of either parasympathetic and sympathetic damage with postural hypotension (PH) (DANϩPHϩ) or predominant parasympathetic damage without PH (DANϩPHϪ), we were able to show an increased response of the respiratory centers to progressive hypercapnia in the former group, whereas the opposite was found in the latter (38) . These findings may suggest a modulatory effect of the sympathetic arm of the autonomic nervous system on the CO 2 responsiveness of the respiratory centers that, in fact, is enhanced when the sympathetic activity is markedly decreased, as in DANϩPHϩ, and reduced when this is not counterbalanced, as in DANϩPHϪ. The operating mechanism, however, is unknown. Because abnormalities in cerebrovascular reactivity (CVR) to different stimuli have been shown in large subsets of patients with long-lasting diabetes, many of whom were young and possibly suffering from autonomic neuropathy (11), we reasoned that, besides a potential direct mechanism, the sympathetic nervous system could indirectly influence the respiratory center output by regulating the cerebral blood flow (CBF) in the presence of effective stimuli. To verify this hypothesis, the CVR to CO 2 was assessed in diabetic patients with different degrees of dysautonomy, while the ventilatory and neuromuscular response of the respiratory drive to progressive hypercapnia was monitored.
METHODS
Subjects. Forty-five male diabetic patients, 15 without (DANϪ) and 30 with (DANϩ) diabetic autonomic neuropathy were recruited from the Dipartimento di Medicina Interna e Scienze Endocrine e Metaboliche of University of Perugia and enrolled in the study after they had given fully informed consent. The protocol was approved by the local ethics committee and was in accordance with the Helsinki Declaration.
All patients on treatment with regular insulin before each meal and intermediate-acting insulin at bedtime were in a satisfactory metabolic control (Table 1) . No drugs able to influence pulmonary or cardiovascular function were being taken by the patients.
Autonomic neuropathy was assessed by the following classic cardiovascular tests: 1) heart rate (HR) variation to deep breathing; 2) HR response to Valsalva maneuver; 3) HR response from lying down to standing; 4) postural fall in systolic blood pressure; and 5) diastolic blood pressure rise to sustained handgrip (13) . According to the literature (2), each test result was scored 0 if normal, 1 if borderline, and 2 if abnormal. The diabetic patients were considered suffering from autonomic neuropathy only if the total score was Ն4. Fifteen of 30 DANϩ patients had predominant parasympathetic involvement of the autonomic nervous system, that is, an impairment of at least two tests of deep breathing, Valsalva maneuver, and lying down to standing, but a normal increase in diastolic blood pressure to sustained handgrip and lack of PH, and we referred to them as DANϩPHϪ. The remaining 15 DANϩ exhibited severe autonomic neuropathy, that is, parasympathetic damage associated with an overt sympathetic damage as reflected by PH, i.e., an upright fall of systolic blood pressure Ͼ30 mmHg and impaired response to sustained handgrip, i.e., an increment of diastolic blood pressure Ͻ16 mmHg, and we referred to them as DANϩPHϩ (4, 5, 29) . One patient in the DANϪ group, four in the DANϩPHϪ group, and nine in the DANϩPHϩ group had preproliferative retinopathy; two DANϩPHϩ patients had proliferative retinopathy. The remaining patients had no proliferative or background retinopathy. Two subjects in the DANϪ group, seven in the DANϩPHϪ group, and 10 in the DANϩPHϩ group had microalbuminuria (overnight urinary protein excretion of 20-200 g/min); one subject in the DANϩPHϪ group and four subjects in the DANϩPHϩ group had proteinuria (Ͻ2 g/24 h), but none of them had serum creatinine Ͼ1.5 mg/dl. Two patients in the DANϩPHϩ group had symptoms related to autonomic dysfunction, that is, nocturnal watery diarrhea and gustatory sweating, respectively.
All patients had to be normotensive, without evidence or history of ischemic heart and cerebrovascular disease. Duplex scans of the carotid arteries had to show no or only mild (Ͻ30%) stenosis of the internal carotid artery. None of the patients studied had symptoms or signs of endocrine or metabolic disease other than diabetes. No respiratory symptoms were observed or reported at the time of the study. Fifteen male normal subjects recruited from the University staff were studied as the control (C) group (Table 1) .
Study design. All patients and C subjects underwent pulmonary function tests including spirometry, flow/volume curves, determination of lung volumes (by multiple-breath nitrogen washout technique), and measurements of maximal inspiratory (MIP) and expiratory mouth pressures (MEP). All tests were performed with subjects in the sitting position, wearing a nose clip, and breathing through a mouthpiece connected to a computerized measuring system (MedGraphics 1070; Medical Graphics, St. Paul, MN). The predicted values for volumes and flows were those proposed by the European Community for Coal and Steel (31) . Measurements of MIP and MEP, sustained for at least 1 s, which could not differ by Ͼ5%, were obtained in triplicate at functional residual capacity by a differential pressure transducer (Ϯ300 cmH 2 O; Validyne, Northridge, CA). Subjects were comfortably seated, wearing a nose clip, and performed maximal inspiratory and expiratory efforts against an obstructed mouthpiece with a small leak (internal diameter ϳ2 mm) during inspiration to prevent the subjects from generating pressures with their facial muscles. The mean of the two best efforts was considered for analysis. Predicted values for MIP and MEP were those proposed by Cook et al. (7) . Minute ventilation (V E), tidal volume (VT), and respiratory rate (RR) were measured at rest from the time-integrated flow signal with the subjects breathing room air in the seated position through a two-way, non-rebreathing, balloon shutter occlusion valve (Hans-Rudolph, Kansas City, MO). Randomly, during each four to eight breaths during expiration, the inspiratory line was silently closed by automatically inflating the balloon with a computer-supported pneumatic system (respiratory pressure module MedGraphics, Medical Graphics). The mouth pressure was measured during the following occluded inspiration at a side port on the occlusion valve, which was connected to a pressure transducer (Ϯ150 cmH 2 O; Validyne) through a noncompliant polyethylene catheter (internal diameter 1.4 mm; length 95 cm). The value of mouth pressure with occluded airways, calculated 100 ms after the beginning of the inspiration (P 0.1 ), was displayed by the computer (respiratory pressure module MedGraphics, Medical Graphics) (41) . Baseline P 0.1 was obtained as a mean of at least eight values of occlusion pressure, after the lowest and the highest were rejected. CO 2 was continuously sampled at the mouth, and the expiratory end-tidal CO 2 partial pressure (PET CO 2 ) was measured breath by breath by a rapid infrared CO 2 analyzer (gas analyzer module, CPX MedGraphics, Medical Graphics).
The rebreathing test was performed according to the Read method (32) . While sitting, after a 5-min period of adaptation to the circuit, each subject started to breathe a gas mixture (7% CO 2 and 93% O 2 ) from a 6-liter anesthetic bag for 4-6 min. During the test, in each four to five breaths, P 0.1 was obtained after the occlusion maneuver, and V E, VT, and RR were calculated from the data averaged from the four breaths preceding each occlusion. For each rebreathing test, V E and P 0.1 were plotted against PET CO 2 , and data were fitted according to the least squares method. The slopes and intercepts of the linear regression were computed. The coefficient of correlation was Ͼ0.97 in all subjects. At a flow rate of 1 l/s, the resistance of the rebreathing circuit was 1.1 cmH 2 O ⅐ l Ϫ1 ⅐ s. Baseline HR and arterial hemoglobin oxygen saturation were obtained by means of an ear pulse oximeter (Biox 3700, Ohmeda, Boulder, CO), and systolic and diastolic arterial blood pressures were obtained by using a sphygmomanometer in all subjects when they were sitting.
In each diabetic group, seven subjects with similar clinical and functional characteristics and seven matched C subjects underwent measurements of mean blood velocity in the middle cerebral artery (MCAV) by ultrasound transcranial Doppler using a Multidop (ESAOTE, Firenze, Italy), both in basal conditions and during rebreathing. After the middle cerebral artery was insonated at a depth of 50 mm, on the temporal window, by using a hand-held 2-MHz probe, MCAV was continuously assessed and measured at each occlusion maneuver for the analysis. The CVR, which is the increase in MCAV expressed as a percentage of baseline MCAV (14), was also computed at different values of PET CO 2 (45, 50, 55, and 60 Torr) and at peak.
In all instances, positioning of the probe and MCAV measurements were made by the same operator (C. Fiorani).
Simultaneously, in these subjects, HR, arterial blood pressure, and, only in diabetic patients in the morning, venous blood samples to measure catecholamine plasma levels were obtained under basal conditions and during the rebreathing test at 55 Torr and at peak value of PET CO 2 .
Blood samples for determination of the plasma epinephrine and norepinephrine, drawn throughout an 18-gauge Teflon catheter inserted into a superficial vein of the forearm, were immediately placed on ice until centrifugation and storage of plasma at Ϫ20°C could be performed. Later analysis was carried out by using the HPLC method (18).
Plasma glucose concentration was measured at baseline and at the end of the rebreathing test in all diabetic patients by means of a Beckman glucose analyzer (Beckman Instruments, Palo Alto, CA). The rebreathing test and ultrasound transcranial Doppler were performed twice, in the morning between 1100 and 1130 and in the afternoon between 1600 and 1630. The values of MCAV, CVR, and slopes of the linear relationship of P0.1 against PET CO 2 (⌬P 0.1 /⌬PET CO 2 ) and of V E against PET CO 2 (⌬V E/⌬PET CO 2 ) averaged from the two tests were considered for the analysis.
Statistical analysis. Comparison of the four groups was performed by using the ANOVA, and orthogonal comparisons were done by adopting the two-tailed unpaired Student's t-test, corrected according to Bonferroni, when allowed by ANOVA. If no assumption about the scatter of the data could be made, the groups were compared by adopting the KruskalWallis test, and, when a significant difference was found, multiple comparisons were performed to compute the difference of the rank's means. Linear correlations were calculated by means of the least squares method. A P value Ͻ 0.05 was considered as significant. Data are expressed as means Ϯ SE.
RESULTS

Pulmonary function tests. Lung volumes, indexes
derived from the flow/volume curve, MIP, and MEP are listed in Table 2 . The pulmonary function parameters were within the normal range in all the groups. Vital capacity was higher in C and DANϪ than in both DANϩ groups (P Ͻ 0.05). Total lung capacity, inspiratory capacity, and forced expiratory volume in the first second were higher in C than in both DANϩ groups (P Ͻ 0.01), and inspiratory capacity and forced expiratory volume in the first second were higher in DANϪ than in DANϩPHϩ (P Ͻ 0.05). Total lung capacity was higher in DANϪ than in DANϩPHϪ (P Ͻ 0.05). The other parameters of lung function did not differ between C and diabetic patients. MIP and MEP were not significantly different among the groups, both as absolute value and as percentage of predicted. Baseline PET CO 2 and arterial hemoglobin oxygen saturation were normal and nearly identical in all groups (Table 2).
Control of breathing. The baseline values of P 0.1 , V E, VT, and RR were similar in all groups (Table 3) . At the end of the rebreathing test, the peak value of PET CO 2 was not different among the groups, amounting to 65 Ϯ 1 Torr for the C subjects and 65 Ϯ 1, 64 Ϯ 1, and 62 Ϯ 1 Torr for DANϪ, DANϩPHϪ, and DANϩPHϩ, respectively. The slope of the linear relationship of ⌬P 0.1 / ⌬PET CO 2 , which was 0.45 Ϯ 0.04 cmH 2 O/Torr in C subjects, was significantly higher in DANϩPHϩ (0.62 Ϯ 0.05 cmH 2 O/Torr) than in DANϪ (0.36 Ϯ 0.04 cmH 2 O/Torr; P Ͻ 0.01) and DANϩPHϪ (0.28 Ϯ 0.03 cmH 2 O/Torr; P Ͻ 0.01). Moreover, the ⌬P 0.1 /⌬PET CO 2 exhibited by DANϩPHϪ was significantly lower than that shown by C subjects (P Ͻ 0.05) ( Table 3) .
The slope of the linear relationship ⌬V E/⌬PET CO 2 amounted to 3.49 Ϯ 0.51 l ⅐ min Ϫ1 ⅐ Torr Ϫ1 in the DANϩPHϩ group and was higher than that in the DANϩPHϪ (2.01 Ϯ 0.18 l ⅐ min Ϫ1 ⅐ Torr Ϫ1 ; P Ͻ 0.05) and DANϪ groups (2.43 Ϯ 0.26 l ⅐ min Ϫ1 ⅐ Torr Ϫ1 ; not significant). ⌬V E/⌬PET CO 2 was 3.31 Ϯ 0.21 l ⅐ min Ϫ1 ⅐ Torr Ϫ1 in the C group and was significantly higher (P Ͻ 0.01) than that in the DANϩPHϪ group (Table 3) . The individual values of the ⌬P 0.1 /⌬PET CO 2 and ⌬V E/ ⌬PET CO 2 slopes are shown for the diabetic groups and C subjects in Fig. 1 . The correlation coefficient of the identity scatterplot of the ⌬P 0.1 /⌬PET CO 2 slope values between the two CO 2 rebreathing tests was 0.91 (P Ͻ 0.001).
MCAV and CVR. Baseline MCAV did not differ among the groups, amounting to 60.3 Ϯ 4.2 cm/s in DANϪ, 58.1 Ϯ 4.8 cm/s in DANϩPHϪ, 63.4 Ϯ 2.4 cm/s in DANϩPHϩ, and 67.3 Ϯ 2.7 cm/s in C, although it was slightly lower in diabetic patients than in C subjects. The increment in MCAV due to progressively increasing hypercapnia was different among the groups (P Ͻ 0.001). In fact, at PET CO 2 of 50 Torr, MCAV was higher in C (87.6 Ϯ 4.5 cm/s) than in DANϪ, DANϩPHϪ, and DANϩPHϩ (72.6 Ϯ 3.4 cm/s, P Ͻ 0.05; 67.2 Ϯ 6.2 cm/s, P Ͻ 0.01; and 73.7 Ϯ 3.4 cm/s, P Ͻ 0.05, respectively), whereas at PET CO 2 of 60 Torr MCAV was higher in DANϩPHϩ (137.8 Ϯ 10.7 cm/s) than in DANϪ (96.4 Ϯ 5.8 cm/s; P Ͻ 0.01) and DANϩPHϪ (84.9 Ϯ 9.0 cm/s; P Ͻ 0.01). At this value of PET CO 2 , MCAV in DANϩPHϪ was significantly lower than in C (111.0 Ϯ 3.8 cm/s, P Ͻ 0.05; Fig. 2 ).
Thus the relationship between MCAV and PET CO 2 that was essentially linear in DANϪ, DANϩPHϪ, and C was exponential in DANϩPHϩ because of the progressively greater increase in MCAV at PET CO 2 values of Ͼ55 Torr (Fig. 2) . Values are means Ϯ SE. P 0.1 , mouth occlusion pressure calculated at 100 ms after the beginning of inspiration; V E, minute ventilation; VT, tidal volume; RR, respiratory rate; ⌬P 0.1 /⌬PET CO 2 , slope of the linear relationship of P 0.1 against PET CO 2 ; ⌬V E/⌬PET CO 2 , slope of the linear relationship of V E against PET CO 2 . Significant difference: * P Ͻ 0.05; † P Ͻ 0.01 vs. C; ‡ P Ͻ 0.01 vs. DANϪ and DANϩPHϪ; §P Ͻ 0.05 vs. DANϩPHϪ. Fig. 1 . Individual values of the slope of the linear relationship between mouth occlusion pressure 100 ms after beginning of inspiration (P 0.1 ; top) and minute ventilation (V E; bottom) against endtidal CO 2 partial pressure (PET CO 2 ). C, control group; DANϪ, diabetic patients without autonomic neuropathy; DANϩPHϪ and DANϩPHϩ, diabetic patients with autonomic neuropathy and without and with postural hypotension, respectively. Solid symbols, subjects who performed transcranial Doppler ultrasonography in each group; solid line, mean; dotted lines, SE. Significant differences: DANϩPHϪ vs. C, * P Ͻ 0.05 and ** P Ͻ 0.01; DANϩPHϩ vs. DANϩPHϪ, ‡P Ͻ 0.05; DANϩPHϩ vs. DANϩPHϪ or DANϪ, †P Ͻ 0.01.
As a result, at PET CO 2 of 50 Torr, CVR was higher in C (32.6 Ϯ 1.4%) than in DANϪ, DANϩPHϪ, and DANϩPHϩ (21.9 Ϯ 5.6%, P Ͻ 0.05; 15.4 Ϯ 1.3%, P Ͻ 0.01; and 16.9 Ϯ 3.7%, P Ͻ 0.01, respectively). Conversely, at PET CO 2 of 60 Torr, CVR was higher in DANϩPHϩ (111.2 Ϯ 17.7%) compared with DANϪ (59.6 Ϯ 5.1%; P Ͻ 0.05), DANϩPHϪ (44.7 Ϯ 5.1%; P Ͻ 0.01), and, although not significantly, also C (64.0 Ϯ 5.1%; P ϭ 0.09) (Fig. 3) .
The coefficient correlation of the identity scatterplot of the CVR values computed at PET CO 2 of 60 Torr between the two transcranial Doppler measurements of MCAV was 0.67 (P Ͻ 0.01).
Catecholamines, HR, and arterial blood pressure. The values of plasma norepinephrine and epinephrine, HR, and mean arterial blood pressure in basal conditions and at the end of the rebreathing test for those diabetic patients and C subjects who performed ultrasound transcranial Doppler are listed in Table 4 . The HR was unchanged in DANϩPHϪ and DANϩPHϩ, and a smaller increase in mean blood pressure was found in these two groups at the end of the rebreathing test. DANϩPHϩ exhibited the lowest increment in plasma catecholamines, and the final level of plasma norepinephrine was significantly lower (P Ͻ 0.01), compared with DANϪ.
The plasma glucose was not different at the end of the CO 2 rebreathing test compared with baseline in each diabetic group.
DISCUSSION
The main findings of the study are that 1) diabetic patients have an impaired CVR (less increase in CBF) with respect to C subjects at PET CO 2 of Ͻ55 Torr (i.e., facing with mild-to-moderate vasodilating stimuli), especially in the presence of dysautonomy; 2) DANϩPHϩ exhibit a greater CVR (greater increase in CBF) than DANϩPHϪ and DANϪ at PET CO 2 levels of Ͼ55 Torr (i.e., facing with stronger vasodilating stimuli); 3) DANϩPHϩ show an increased hypercapnic respiratory drive that is greater than that observed in DANϩPHϪ and DANϪ; 4) DANϩPHϪ are characterized by the lowest CVR and gain of the respiratory center output in response to CO 2 .
To assess CVR to hypercapnia, we measured blood flow velocity in large cerebral arteries by means of ultrasound transcranial Doppler. This method has been widely adopted (14, 20, 22) instead of determination of regional CBF by single-photon emission computerized tomography or by positron emission tomography to evaluate cerebral vasoreactivity or detect abnormalities of cerebral hemodynamics (9, 10, 37) . In fact, changes in velocity and regional CBF have been shown to correlate closely when transcranial Doppler was used simultaneously with these more expensive and technically complex methods.
In the present study, transcranial Doppler ultrasonography was used during progressive hypercapnia, assuming that changes in blood velocity parallel changes in CBF under these conditions also. Because, in normal subjects, the cross-sectional surface area of the basal cerebral arteries is not affected by changes in arterial PCO 2 (1), this assumption is valid for C, but we are not aware of whether this has been demonstrated in DANϩ. However, if the increment in arterial PCO 2 , which is a powerful vasodilating stimulus, had increased the cross-sectional surface area of the middle cerebral artery, especially in DANϩPHϩ, then the increase in MCAV that we recorded in these subjects Fig. 3 . Cerebrovascular reactivity (CVR) computed at PET CO 2 of 50 and 60 Torr in diabetic and C groups during CO 2 rebreathing. Note that CVR is reduced in DANϩPHϩ, as well as in DANϪ and DANϩPHϪ, at lower levels of PET CO 2 with respect to C, whereas it is significantly increased in DANϩPHϩ, compared with the other diabetic groups, at higher levels of PET CO 2 . Data are means Ϯ SE. Significant differences: * P Ͻ 0.05, ** P Ͻ 0.01 vs. C; † P Ͻ 0.01 vs. DANϩPHϪ; ‡P Ͻ 0.05 vs. DANϪ; §P ϭ 0.09 vs. C. Fig. 2 . Mean values of middle cerebral artery mean blood velocity (MCAV) at different levels of PET CO 2 in diabetic groups and C subjects during 2 averaged CO 2 rebreathing tests. MCAV tends to increase linearly with PET CO 2 in C, DANϪ, and DANϩPHϪ and exponentially in DANϩPHϩ. Thus MCAV is lower in DANϪ, DANϩPHϪ, and DANϩPHϩ than in C at PET CO 2 of Ͻ55 Torr and becomes much greater in DANϩPHϩ than in the other diabetic groups at PET CO 2 of Ͼ55 Torr. Data are means Ϯ SE. Significant difference: * P Ͻ 0.05, ** P Ͻ 0.01 vs. C; † P Ͻ 0.01 vs. DANϩPHϩ.
could have only underestimated the increase in their CBF.
Although some studies performed with the singlephoton emission computerized tomography technique have suggested a reduced resting CBF in diabetic patients compared with age-matched C subjects, the lack of significant difference in baseline MCAV between our diabetic and C groups does agree with that reported in several previous works, showing, on average, no reduction either in resting MCAV (14) or in basal global and regional CBF in diabetic patients compared with C subjects (11, 25, 33) .
The reduced CVR found in our diabetic patients is in line with the earlier reports showing less increase in CBF after the administration of either intravenous acetazolamide or a given, relatively low percentage of inspiratory CO 2 (5%) in general populations of patients with long-term diabetes (11, 14) .
Our data, however, show that autonomic neuropathy might play a role in further decreasing CVR in diabetic patients. Indeed, the average slope of the MCAV/ PET CO 2 linear relationship, computed between 45-and 55-Torr PET CO 2 to avoid the dog-leg phenomenon exhibited by these subjects (Fig. 2) , is lower in DANϩPHϪ (1.84 Ϯ 0.17 cm ⅐ s Ϫ1 ⅐ Torr Ϫ1 ; P Ͻ 0.01) and also in DANϩPHϩ (1.92 Ϯ 0.19 cm ⅐ s Ϫ1 ⅐ Torr Ϫ1 ; P Ͻ 0.05) than in DANϪ (2.76 Ϯ 0.29 cm ⅐ s Ϫ1 ⅐ Torr Ϫ1 ). Although this difference was not large enough to induce a significantly lesser CVR in DANϩ than in DANϪ at 50-Torr PET CO 2 (Fig. 3) , nevertheless, it may suggest a cerebral vasoregulatory action of the autonomic nervous system, possibly cholinergic, which is altered in DANϩ. Therefore, besides microangiopathic changes of the brain resistance arterioles, hemorheological changes (14, 23) , and presence of vasoactive substances (14, 23) , autonomic neuropathy could be another cause of reduced reactivity of the cerebral vessels to physiological stimuli in diabetes.
At the same time, a subset of DANϩ, namely the DANϩPHϪ group, exhibited a reduced, neuromuscular, and ventilatory output of the respiratory drive in response to progressive hypercapnia, reflecting a significantly decreased central chemosensitivity.
However, compared with DANϩPHϪ and DANϪ, and even with C, DANϩPHϩ showed a markedly greater increase in MCAV at higher values of PET CO 2 ( Fig. 2) and an enhanced hypercapnic respiratory drive (Fig. 1) . This late, paradoxical increase in CVR does imply an exaggerated vasodilation to severe hypercapnia in diabetic patients with advanced dysautonomy, strongly supporting the idea that, in the presence of stressing stimuli, the sympathetic nervous system may play a role in limiting the increase of the CBF, as well as in modulating the output of the respiratory centers to hypercapnia.
Because physiological activation or electrical stimulation of sympathetic nerves in animals has been shown to induce moderate cerebral vasoconstriction and regulate CBF variations (16, 17, 30) , direct inhibitory action of the sympathetic nervous system on the cerebral vascular bed in the face of strong vasodilating stimuli may actually be envisaged in humans. Moreover, alterations of adrenergic and cholinergic innervation of brain arterioles have been described in experimental diabetes (14) .
Also, the responsiveness of the central drive to CO 2 could be directly modulated by the sympathetic nervous system. Indeed, pulmonary sympathetic afferents have been found in dogs and monkeys, and the stimulation of nerves carrying these fibers was able to inhibit the phrenic discharge in these anesthetized animals (21) . In addition, in the absence of catecholaminemediated peripheral effect, central release of norepinephrine at respiratory-related units in the central nervous system has been shown to inhibit ventilatory output through an ␣-receptor-mediated action (3, 6) . Accordingly, greater CVR and enhanced hypercapnic respiratory drive shown by DANϩPHϩ could be seen as independent, different expressions of the same phenomenon represented by the defective central modulation of the sympathetic autonomic nervous system, whereas the opposite could be invoked in DANϩPHϪ.
However, a close, direct correlation between CVR, reflecting the increment of CBF, and the P 0.1 values (or the ⌬P 0.1 /⌬PET CO 2 slope), reflecting the response of the respiratory centers, is present during progressive hypercapnia in DANϩ (Fig. 4) . Such a strong relationship tends to suggest a causal link between these two phenomena, possibly indicating that a greater or lesser CO 2 load carried out on the central chemoreceptors as a consequence of an excessive or reduced vasodilation in the presence of increasing circulatory CO 2 levels can markedly influence the output of the respiratory centers to CO 2 . In other words, the hypercapnic central inspiratory drive, enhanced in DANϩPHϩ and depressed in DANϩPHϪ, would be an expected, normal response toward a different acidotic stimulus and would be relatively increased in DANϩPHϩ or reduced in DANϩPHϪ, due, in both instances, to an impaired CVR.
No correlation was found between CVR and the ⌬P 0.1 /⌬PET CO 2 slope or the P 0.1 values during CO 2 rebreathing in DANϪ and C.
It should be noted, however, that the vascular responses to progressive hypercapnia were assessed in the forebrain circulation (middle cerebral artery) rather than in the hindbrain circulation, where, because of the lesser sympathetic innervation to blood vessels, the changes in CVR could be quantitatively different and more crucial in influencing the activity of the central chemoreceptors, especially in these subjects.
The results of the present study differ to some extent from those of other investigations carried out in patients with long-term diabetes and also in diabetic patients with disturbed autonomic innervation, in whom a preserved or slightly impaired CVR to administration of acetazolamide (33), CO 2 inhalation (15), or blood pressure changes (8) was found, suggesting a minor role of the autonomic neuropathy in the cerebrovascular dysregulation in diabetes. Selection of patients, different techniques, and stimuli could explain the discrepancies. In fact, in obvious contrast to the aforementioned reports, in the present study the diabetic patients were carefully matched and categorized according to the presence and severity of the autonomic neuropathy, and their change in MCAV to hypercapnia was explored at different levels of CO 2 by progressively increasing the magnitude of the stimulus.
These findings are clinically relevant because diabetic patients with dysautonomy might be at particular risk for developing cerebrovascular disease. Both the response to hypotension and the ability to increase CBF to cope with increasing metabolic demand could be further affected if the cerebral vasodilating response is further compromised by the presence of autonomic neuropathy. Moreover, in diabetic patients with more advanced dysautonomy, the excessive CVR after intense vasodilating stimuli might also be a negative event. For instance, in the presence of cerebral transient ischemia, it could allow an increased luxury flow in collaterally perfused vascular territories and thus divert blood flow from the ischemic area, thus accelerating the course of cerebral ischemia. This phenomenon might contribute to the greater prevalence of thrombotic stroke than transient ischemic attack in patients with diabetes, compared with the general population (23) .
Finally, a possible explanation of the controversial results on the control of breathing in diabetic patients with autonomic neuropathy is given. In fact, a double response of the respiratory drive to hypercapnia is clearly shown by DANϩ, depressed in DANϩPHϪ, and enhanced in DANϩPHϩ. This finding suggests a modulatory effect, likely mediated through the CBF regulation and exerted by the sympathetic nervous system on the central chemosensitivity, which, consequently, is either reduced or augmented in these patients.
In conclusion, the presence and severity of autonomic neuropathy does affect the CVR to CO 2 and influence the hypercapnic drive to breathing in diabetic patients.
